Research Topics
| R H DworkinSummaryAffiliation: University of Rochester Country: USA Publications
| Collaborators
|
Detail Information
Publications
Placebo response in clinical trials of depression and its implications for research on chronic neuropathic painRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Neurology 65:S7-19. 2005....
Health care expenditure burden of persisting herpes zoster painRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Pain Med 9:348-53. 2008....
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Departments of Anesthesiology and Neurology and Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY 14642, USA
Pain 153:1148-58. 2012....
Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?Robert H Dworkin
Department of Anesthesiology, Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Pain 153:869-75. 2012..The results suggest that a considerable number of patients with PHN in the community are not receiving evidence-based treatment...
Symptom profiles differ in patients with neuropathic versus non-neuropathic painRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Pain 8:118-26. 2007....
Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costsRobert H Dworkin
Departments of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
J Pain 11:360-8. 2010..The results also increase understanding of the economic burden of PHN and painful DPN and provide a basis for evaluating the impact on health care costs of new interventions for their treatment and prevention...
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Pain 146:238-44. 2009..Such determinations must be conducted on a case-by-case basis, and are ideally informed by patients and their significant others, clinicians, researchers, statisticians, and representatives of society at large...
Core outcome measures for chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Pain 113:9-19. 2005
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)Robert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA
Pain 144:35-42. 2009..These results provide a basis for use of the SF-MPQ-2 in future clinical research, including clinical trials of treatments for neuropathic and non-neuropathic pain conditions...
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zosterRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA
Pain 142:209-17. 2009....
Recommendations for the management of herpes zosterRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
Clin Infect Dis 44:S1-26. 2007..Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ...
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgiaRobert H Dworkin
Department of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
J Pain 9:S37-44. 2008..PERSPECTIVE: Comprehensive assessments of pain are necessary for clinical research on the epidemiology, natural history, pathophysiologic mechanisms, treatment, and prevention of pain in herpes zoster and PHN...
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Pain 9:105-21. 2008....
Pharmacologic management of neuropathic pain: evidence-based recommendationsRobert H Dworkin
University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Pain 132:237-51. 2007..Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examining treatment of central NP are lacking and should be a priority for future research...
Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zosterRobert H Dworkin
Department of Anesthesiology, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA
J Am Geriatr Soc 55:1168-75. 2007..To determine the healthcare costs of acute and chronic pain associated with herpes zoster...
Recommendations for the pharmacological management of neuropathic pain: an overview and literature updateRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, NY 14642, USA
Mayo Clin Proc 85:S3-14. 2010..The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacological management of neuropathic pain and to provide a brief overview of these recent studies...
Treatment and prevention of postherpetic neuralgiaRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Clin Infect Dis 36:877-82. 2003..Research on administration of the varicella-zoster vaccine to prevent herpes zoster and on treatment of patients who have herpes zoster with combined antiviral and analgesic therapy to prevent PHN is discussed...
Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT databaseR H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Osteoarthritis Cartilage 19:483-92. 2011..Identifying outcome measures with greater responsiveness to treatment is important to increase the assay sensitivity of RCTs...
Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathyRobert H Dworkin
Department of Anesthesiology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA
J Am Geriatr Soc 59:827-36. 2011..To determine and compare healthcare utilization and costs for younger and older adults with postherpetic neuralgia (PHN) and painful diabetic peripheral neuropathy (DPN)...
Accelerating the development of improved analgesic treatments: the ACTION public-private partnershipRobert H Dworkin
Departments of Anesthesiology and Neurology and Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Pain Med 12:S109-17. 2011..The results of these activities have the potential to inform and accelerate the development of improved pain management interventions of all types, not just pharmacologic treatments...
An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanismsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York, USA
Clin J Pain 18:343-9. 2002..An overview is presented of neuropathic pain syndromes, their characteristic symptoms and signs, and recent approaches to identifying their pathophysiologic mechanisms...
Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse eventsRobert H Dworkin
Departments of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
J Pain 12:416-24. 2011..Increased understanding of such global measures may facilitate development of clinical trial outcomes that allow patients to evaluate with minimal burden those aspects of the treatment experience they consider personally meaningful...
Acute pain in herpes zoster: the famciclovir database projectR H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA
Pain 94:113-9. 2001....
Prospects for the prevention of postherpetic neuralgia in herpes zoster patientsR H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
Clin J Pain 16:S90-100. 2000..The prevention of PHN would lead to major reductions in disability, suffering, and the use of health care resources...
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Meedicine and Dentistry, Rochester, NY 14642
Arch Neurol 60:1524-34. 2003..Continued progress in basic and clinical research on the pathophysiologic mechanisms of neuropathic pain may make it possible to predict effective treatments for individual patients by application of a pain mechanism-based approach...
Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialR H Dworkin
University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Neurology 60:1274-83. 2003..To evaluate the efficacy and safety of pregabalin in the treatment of postherpetic neuralgia (PHN)...
Fibromyalgia from the perspective of neuropathic painRobert H Dworkin
University of Rochester Medical Center, Rochester, NY, USA
J Rheumatol Suppl 75:1-5. 2005
Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patientsR H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York 14642, USA
J Infect Dis 178:S76-80. 1998..In addition, they demonstrated that treatment of acute herpes zoster patients with famciclovir significantly reduces both the duration and prevalence of PHN...
Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathiesDavid N Herrmann
Department of Neurology, University of Rochester Medical Center, 601 Elmwood Ave, Box 673, Rochester, NY 14642, USA
Muscle Nerve 33:42-8. 2006..Further studies are required to clarify precisely the mechanism and site of action of the lidocaine patch in patients with peripheral neuropathic pain...
A randomized, placebo-controlled trial of bupropion sustained release in chronic low back painJennifer Katz
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Pain 6:656-61. 2005..We studied bupropion because it inhibits the reuptake of both norepinephrine and dopamine, but found no evidence of efficacy in patients with non-neuropathic chronic low back pain...
Clinical trial outcome in neuropathic pain: relationship to study characteristicsJennifer Katz
Department of Psychology, State University of New York College at Geneseo, NY, USA
Neurology 70:263-72. 2008..It is unclear whether these trials were unsuccessful because the medications truly lack efficacy or whether characteristics of the trials compromised the demonstration of treatment benefits...
Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgiaElna M Nagasako
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York, USA
J Am Acad Dermatol 46:834-9. 2002..The results indicate that severe rash is more common in patients with herpes zoster who are older and who have more severe acute pain and confirm that severe rash is a risk factor for prolonged pain...
Risk factors for postherpetic neuralgia in patients with herpes zosterBeth F Jung
University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Neurology 62:1545-51. 2004....
Risk factors for acute pain and its persistence following breast cancer surgeryJennifer Katz
Department of Psychology, State University of New York College at Geneseo, Geneseo, NY, USA
Pain 119:16-25. 2005....
Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathyJ Robinson-Papp
Department of Neurology, Mount Sinai, School of Medicine, New York, NY 10029, USA
Pain 151:732-6. 2010..This finding holds true regardless of demographic factors, depression or substance use history...
The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsivenessDavid C Foster
Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Obstet Gynecol 113:825-32. 2009..We report upon the reliability, validity, and responsiveness to change of the Tampon Test as an outcome measure for vulvodynia clinical trials...
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosisLahar R Mehta
Neuroimmunology Unit, University of Rochester Medical Center, 601 Elmwood Avenue, Box 605, Rochester, NY 14586, USA
Nat Clin Pract Neurol 5:82-92. 2009..We propose that the potential role of PUFAs as disease-modifying, anti-inflammatory treatments for MS should be revisited in proof-of-concept trials that use accepted MRI outcome measures...
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with painDennis C Turk
Department of Anesthesiology, University of Washington, Seattle, WA 98195, USA
Pain 137:276-85. 2008..These multiple outcomes should be considered when evaluating the efficacy and effectiveness of chronic pain treatments...
Treatment of neuropathic pain: an overview of recent guidelinesAlec B O'Connor
Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Am J Med 122:S22-32. 2009..For all treatments for neuropathic pain, long-term studies, head-to-head comparisons, and studies of treatment combinations are a priority for future research...
Broadening the spectrum of controls for skin biopsy in painful neuropathiesDavid N Herrmann
Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Muscle Nerve 42:436-8. 2010..Distal-leg ENFD/morphology in MS DLLBP patients did not differ significantly from that of healthy controls. This study extends the range of ENFD controls and further supports use of ENFD assessment in SFSN...
Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trialDavid C Foster
Departments of Obstetrics and Gynecology, Biostatistics, Anesthesiology and Neurology, and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Obstet Gynecol 116:583-93. 2010..To estimate the efficacy of common treatments for vulvodynia: topical lidocaine monotherapy, oral desipramine monotherapy, and lidocaine-desipramine combined therapy...
Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted womenDavid C Foster
Department of Obstetrics and Gynecology and Department of Anaesthesia, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Pain 117:128-36. 2005..Conclusion. VVS patients show enhancement of post-capsaicin pain response extending far beyond the anatomic location of the primary complaint...
Ion channel targets and treatment efficacy in neuropathic painJohn D Markman
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Pain 7:S38-47. 2006..Improved efficacy of ion channel modulators hinges upon further elucidation of the relationship between signs and symptoms of pain and underlying pathophysiology...
An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathyDavid N Herrmann
Department of Neurology, University of Rochester, Rochester, New York 14642, USA
Pain Med 6:379-84. 2005..We have therefore conducted a safety, tolerability, and effectiveness study of the lidocaine patch 5% in painful idiopathic distal sensory polyneuropathy...
Acute pain in herpes zoster and its impact on health-related quality of lifeJennifer Katz
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
Clin Infect Dis 39:342-8. 2004..The increasing incidence of herpes zoster that can be anticipated as the population ages requires that clinical trials that examine interventions to prevent or treat herpes zoster pain be given a high priority...
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathyRichard L Barbano
Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Arch Neurol 61:914-8. 2004..The treatment of painful diabetic polyneuropathy (DPN) is often inadequate and frequently limited by the systemic adverse effects of medications, necessitating the evaluation of novel treatments...
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk
Department of Anesthesiology, University of Washington, Seattle, WA 98195, USA
Pain 106:337-45. 2003....
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Pain 149:177-93. 2010....
Pharmacotherapy of painful diabetic neuropathyRichard Barbano
University of Rochester, Department of Neurology, 601 Elmwood Avenue, Rochester, NY 14642, USA
Curr Pain Headache Rep 7:169-77. 2003..There is great hope that the future may hold treatments that would prevent nerve damage...
Treatment of herpes zoster and postherpetic neuralgiaRobert W Johnson
Pain Management Clinic, Bristol Royal Infirmary, Bristol BS2 8HW, University of Rochester Medical Centre, New York, USA
BMJ 326:748-50. 2003
Contributions of physical and sexual abuse to women's experiences with chronic pelvic painEllen L Poleshuck
Wynne Center for Family Research, Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Reprod Med 50:91-100. 2005..To examine the roles of physical and sexual abuse in women with chronic pelvic pain using multi-dimensional pain assessment and to compare the chronic pelvic pain experiences of women with physical abuse to those of women with sexual abuse...
Risk factors for chronic pain following breast cancer surgery: a prospective studyEllen L Poleshuck
Department of Psychiatry, University of Rochester School of Medicine and Dentistry, New York 14642, USA
J Pain 7:626-34. 2006....
Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zosterJennifer Katz
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
J Pain 6:782-90. 2005..PERSPECTIVE: The results of this prospective study of patients with herpes zoster suggest that future research on the mechanisms and prevention of PHN should consider psychosocial as well as neurobiologic processes...
What should be the core outcomes in chronic pain clinical trials?Dennis C Turk
Department of Anesthesiology, University of Washington, Seattle, Washington, USA
Arthritis Res Ther 6:151-4. 2004..In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted...
Pain associated with multiple sclerosis: systematic review and proposed classificationAlec B O'Connor
Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
Pain 137:96-111. 2008..Suggestions for future studies that would increase understanding of the natural history, mechanisms, and treatment of pain in patients with MS are presented...
Toward a model of the pathogenesis of chronic painR H Dworkin
Departments of Anesthesiology and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Semin Clin Neuropsychiatry 4:176-85. 1999..The vulnerability-diathesis-stress model can serve as a basis for designing and analyzing studies of the interaction among biological, psychological, and social risk factors for chronic pain...
Neuropathic pain associated with non-surgical treatment of breast cancerBeth F Jung
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA
Pain 118:10-4. 2005
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical TrialsDennis C Turk
Department of Anesthesiology, University of Washington, Seattle, 98195, USA
Pain 139:485-93. 2008....
Neuropathic pain following breast cancer surgery: proposed classification and research updateBeth F Jung
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY 14642, USA
Pain 104:1-13. 2003
Herpes zoster and the prevention of postherpetic neuralgia: beyond antiviral therapyRichard B Tenser
Neurology 65:349-50. 2005
Inadequate evidence for a revised definition of postherpetic neuralgia (PHN)Robert H Dworkin
Pain 128:189-90; author reply 190-2. 2007
The impact of neuropathic pain on health-related quality of life: review and implicationsMark P Jensen
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195 6490, USA
Neurology 68:1178-82. 2007....
Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a reviewAmy M Barrett
RTI Health Solutions, Research Triangle Park, North Carolina 27709 2194, USA
Pain Med 8:S50-62. 2007..The literature examining the epidemiology, quality of life burden, cost, and treatment of diabetic peripheral neuropathy pain (DPNP) in U.S. adults was reviewed...
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?Mark P Jensen
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, 98195 6490, USA
J Pain 7:644-53. 2006..These findings suggest that measures of these specific pain domains could play an important role in understanding the impact of pain on patient functioning...
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandableJohn T Farrar
Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Pain Symptom Manage 31:369-77. 2006..Whether as a primary or secondary approach to a clinical trial of pain therapy, the display of data in a CPRA format may be useful in the understanding of results and applicability to patient care...
Natural history and treatment of herpes zosterKenneth E Schmader
Division of Geriatrics, Department of Medicine, Duke University Medical Center and Geriatric Research, Education and Clinical Center, Durham VA Medical Center, Durham, NC 27705, USA
J Pain 9:S3-9. 2008..PERSPECTIVE: This article presents information on the clinical features and treatment of herpes zoster. This information will help clinicians diagnose and manage herpes zoster pain...
PregabalinRobert H Dworkin
Nat Rev Drug Discov 4:455-6. 2005
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain ScaleMark P Jensen
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
J Pain 6:98-106. 2005..This research might be used to help clinicians target analgesics to match the specific qualities associated with a patient's pain and to better understand the mechanisms of analgesic effects in drug development programs...
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trialLeslie J Crofford
University of Michigan, Ann Arbor, USA
Arthritis Rheum 52:1264-73. 2005..FMS affects an estimated 2% of the population, predominantly women. This trial was designed to evaluate the efficacy and safety of pregabalin, a novel alpha(2)-delta ligand, for treatment of symptoms associated with FMS...
An interdisciplinary expert consensus statement on assessment of pain in older personsThomas Hadjistavropoulos
Centre on Aging and Health, University of Regina, Regina, SK, Canada
Clin J Pain 23:S1-43. 2007..The literature underlying the consensus recommendations is reviewed. Multiple revisions led to final reviews of 2 complete drafts before consensus was reached...
Congenital insensitivity to pain: an updateElna M Nagasako
Washington University School of Medicine, St. Louis, MO, USA
Pain 101:213-9. 2003
Geographic and racial aspects of herpes zosterElna M Nagasako
Washington University School of Medicine, St. Louis, Missouri, USA
J Med Virol 70:S20-3. 2003..These results suggest that racial group and geographic region may be independent factors associated with age at onset in patients with herpes zoster...
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)Rafael Harpaz
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, USA
MMWR Recomm Rep 57:1-30; quiz CE2-4. 2008..Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity...
Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendationsPatrick J McGrath
Dalhousie University and IWK Health Center, Halifax, Canada
J Pain 9:771-83. 2008....
Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased riskMichael T Smith
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe Street, Meyer 101, Baltimore, MD 21287, USA
Pain 111:201-8. 2004....
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendationsDennis C Turk
University of Washington, Seattle, WA 98195, USA
Pain 125:208-15. 2006
